Associate Director
Novartis
Cambridge, Massachusetts, United States
Targeted Protein Degrader Therapeutics: Opportunities and Challenges (S16)
Wednesday, November 20, 2024
9:00 AM - 12:00 PM CT
Wednesday, November 20, 2024
9:00 AM - 9:05 AM CT